The Gross Margin of EPIRUS Biopharmaceuticals Inc (EPRSQ) is 82.17%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2017-12-31 | 82.17% |
| 2016-12-31 | 82.17% |